Latest News about gene therapy
Recent news which mentions gene therapy
   YouthBio Therapeutics Announces Significant Results from Joint Study with Dr. Ocampo Demonstrating Amelioration of Age-Related Cognitive Decline
   
  
  August 06, 2024
  From PRLog
 From Benzinga
 From Benzinga
 From Benzinga
 
   Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol
   
  
  
  April 02, 2024
  From Benzinga
 
   Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles
   
  
  
  June 08, 2023
  From Benzinga
 
   FDA AdComm Narrowly Supports Approval Of Sarepta's Gene Therapy For Rare Neuromuscular Disorder
   
  May 15, 2023
  Tickers 
   SRPT
  
  
  From Benzinga
 
   $2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis
   
  
  
  April 13, 2023
  From Benzinga
 
   6 Questions With Rocket Pharma's CEO On World Health Day: How The Biotech Is 'Changing The Narrative'
   
  
  
  April 07, 2023
  From Benzinga
 
   Tesla, Meta, Thermogenesis, Adobe, UiPath: Why These 5 Stocks Are Drawing Investors' Attention Today
   
  
  
  March 15, 2023
  From Benzinga
 
   Regenxbio Says Diabetic Retinopathy Gene Therapy Shows Meaningful Improvements In Disease Severity
   
  November 03, 2022
  Tickers 
   RGNX
  
  
  From Benzinga
 From PRUnderground
 
   This COVID-19 Shot Stock Could Have Eye Disease Gene Therapy As Significant Driver, Mizuho Analyst Says
   
  August 23, 2022
  Tickers 
   OCGN
  
  
  From Benzinga
 
   Bluebird's Gene Therapy Scores US Approval For Genetic Blood Disorder, Probably The Most Expensive
   
  August 17, 2022
  Tickers 
   BLUE
  
  
  From Benzinga
 
   Homology Medicines Announces Preclinical Gene Therapy Candidate For Genetic Storage Disorder
   
  August 12, 2022
  Tickers 
   FIXX
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Analysts Consider CRISPR Therapeutics' Blood Disorder Trial Data Encouraging, Impressive
   
  
  
  June 13, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.